The University of Arkansas for Medical Sciences (UAMS) has opened a new chemotherapy infusion center at the Winthrop P. Rockefeller Cancer Institute.
This new infusion center, located on the sixth floor of the institute, is designed to serve patients with blood cancers, including leukemia, lymphoma and multiple myeloma, and those participating in clinical trials. In total, the center will have a capacity of 50 patients. Twenty patients will be treated in private rooms, 20 will be in open pods and 10 in infection control rooms.
“This new state-of-the-art infusion center will greatly expand our ability to provide essential cancer therapies for our patients, as well as provide them with the warm, comfortable environment they deserve,” UAMS Chancellor Cam Patterson, M.D., MBA, said in a statement.
Dubbed Infusion Center B, the new center will host the first Phase 1 Clinical Trial Unit, which will provide new cancer therapies unavailable anywhere else in the state, according to a UAMS news release.
In 2021, UAMS plans to open two more areas in the Winthrop P. Rockefeller Cancer Institute. One of these areas will be an expanded Breast Center on the third floor of the facility, and the second area will be additional clinic space on the seventh floor.
Image courtesy of Winthrop P. Rockefeller Cancer Institute